Litigators rarely get to reverse their biggest loss. Rarer still is the chance to overturn the biggest patent damages award in history. A February 2011 ruling by the U.S. Court of Appeals for the Federal Circuit allowed Wilmer Cutler Pickering Hale and Dorr partner William Lee to do both.
The ruling came about a year and a half after a federal jury in Marshall, Texas, found that Humira, a major arthritis drug made by Wilmer client Abbott Laboratories, infringed a patent issued to Johnson & Johnson’s Centocor Ortho Biotech, Inc., and New York University. The verdict included a $1.67 billion damages award against Abbott. Says Lee: “Happily you don’t lose cases of this magnitude very often. If you do, then you don’t have them to lose.” Abbott rejected his offer to bring in another firm for the appeal—a decision that paid off when the Federal Circuit found the patent claims at issue invalid due to insufficient written description.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
